AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15109992 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory tasks in Chinese (L1)
Number of subjects: 12
Study 15109992 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory tasks in English (L2)
Number of subjects: 12
Study 15109992 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional MRI imaging during working memory tasks
Number of subjects: 12
Study 15109992 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume of activation in left opercularis region, left parietal lobule, and right precentral region
Number of subjects: 12
Study 11338045 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NC)
Number of subjects: 76
Study 11338045 — intervention group
Group type: COMPARATOR
Intervention: No neoadjuvant chemotherapy (Control)
Number of subjects: 76
Study 10423597 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (20 mg/d)
Number of subjects: 18
Study 10423597 — intervention group
Group type: COMPARATOR
Intervention: Gemfibrozil (600 mg twice a day)
Number of subjects: 18
Study 7515382 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylometazoline 0.1% vasoconstrictor nasal spray
Number of subjects: 80
Study 7515382 — intervention group
Group type: COMPARATOR
Intervention: Plain Magill red rubber endotracheal tube
Number of subjects: 80
Study 3665737 — intervention group
Group type: EXPERIMENTAL
Intervention: Piretanide
Number of subjects: 0
Study 3665737 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 0
Study 3665737 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 0
Study 3665737 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine and Acebutolol
Number of subjects: 0
Study 3665737 — intervention group
Group type: COMPARATOR
Intervention: All three drugs
Number of subjects: 0
Study 30043749 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 314
Study 30043749 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 314
Study 30043749 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study 27830836 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (counseling on diet and exercise every 3 months via phone call)
Number of subjects: 280
Study 27830836 — intervention group
Group type: COMPARATOR
Intervention: Control (counseling in annual checkups without regular intervention)
Number of subjects: 280
Study 25518308 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 219
Study 25518308 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine antenatal care)
Number of subjects: 219
Study 22436156 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnitine-supplemented diet
Number of subjects: 16
Study 22436156 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 16
Study 20339969 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg daily for 4 weeks)
Number of subjects: 38
Study 17629923 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone propionate (SFC) 50/100 mug twice daily
Number of subjects: 0
Study 17629923 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 100 mug twice daily
Number of subjects: 0
Study 15668601 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein containing 52 mg genistein, 41 mg daidzein, and 6 mg glycitein daily for 1 year
Number of subjects: 202
Study 15668601 — intervention group
Group type: COMPARATOR
Intervention: Milk protein (placebo) daily for 1 year
Number of subjects: 202
Study 15668601 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein
Number of subjects: 202
Study 15668601 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 12029552 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine-131 iodide (120 MBq) as diagnostic agent, followed by ablation activity of 131I iodide (4,000 MBq) administered 3-38 days later.
Number of subjects: 26
Study 12029552 — intervention group
Group type: COMPARATOR
Intervention: Iodine-123 iodide (200 MBq) as diagnostic agent, followed by ablation activity administered 5-47 days later.
Number of subjects: 26
Study 10408210 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiotape
Number of subjects: 0
Study 10408210 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotape
Number of subjects: 0
Study 10408210 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 7584730 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 10
Study 7584730 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2138186 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine, 0.5 mg twice daily
Number of subjects: 10
Study 2138186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 394315 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavitary streptokinase/streptodornase
Number of subjects: 0
Study 394315 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral streptokinase/streptodornase
Number of subjects: 0
Study 394315 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 30706792 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking exercise program, 24 weeks, five times per week
Number of subjects: 100
Study 30706792 — intervention group
Group type: COMPARATOR
Intervention: Routine activities (Control group)
Number of subjects: 100
Study 28816195 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tieback
Number of subjects: 25
Study 28816195 — intervention group
Group type: EXPERIMENTAL
Intervention: NiTi coil spring
Number of subjects: 25
Study 26014294 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (B) 15 mg/kg intravenously plus Carboplatin (CP) and Paclitaxel (CP)
Number of subjects: 276
Study 26014294 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pl) plus Carboplatin (CP) and Paclitaxel (CP)
Number of subjects: 276
Study 23907665 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK1322322 (oral or intravenous administration)
Number of subjects: 62
Study 23907665 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral doses of GSK1322322 (1,000 and 1,500 mg)
Number of subjects: 62
Study 23907665 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat IV doses of GSK1322322 (500 to 1,500 mg twice daily)
Number of subjects: 62
Study 23907665 — intervention group
Group type: EXPERIMENTAL
Intervention: Supratherapeutic single IV doses of GSK1322322 (2,000 and 3,000 mg)
Number of subjects: 62
Study 20717049 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (1.25 mg in 0.05 mL) injected around the valve body after surgery
Number of subjects: 20
Study 20717049 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (0.4 mg/mL for 3 min) applied before valve implantation
Number of subjects: 20
Study 20717049 — intervention group
Group type: COMPARATOR
Intervention: Ahmed valve only (control group)
Number of subjects: 20
Study 19013598 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 to 100 mg)
Number of subjects: 203
Study 19013598 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study 16420138 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced counseling and support intervention
Number of subjects: 406
Study 16420138 — intervention group
Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 406
Study 12463600 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic HSCT from related donors other than genotypically HLA‐matched siblings
Number of subjects: 30
Study 12463600 — intervention group
Group type: COMPARATOR
Intervention: Control group (HSCT from genotypically HLA‐matched siblings)
Number of subjects: 30
Study 10354813 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture at the Lung Point
Number of subjects: 23
Study 10354813 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupuncture)
Number of subjects: 23
Study 7593877 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent training and marital problem solving intervention for 10 months
Number of subjects: 42
Study 7593877 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal treatment investment
Number of subjects: 42
Study 2199847 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (Botox) injections
Number of subjects: 55
Study 2199847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 2199847 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (Botox) injections (higher dose during open phase)
Number of subjects: 55
Study 6171899 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (52 patients)
Number of subjects: 116
Study 6171899 — intervention group
Group type: COMPARATOR
Intervention: Control (64 patients)
Number of subjects: 116
Study 30568009 — intervention group
Group type: EXPERIMENTAL
Intervention: Honda Stride Management Assist (SMA) exoskeleton
Number of subjects: 50
Study 30568009 — intervention group
Group type: COMPARATOR
Intervention: Functional gait training
Number of subjects: 50
Study 28898378 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE, 0.625 mg/d) plus medroxyprogesterone acetate (MPA, 2.5 mg/d) (n=8506)
Number of subjects: 27347
Study 28898378 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE, 0.625 mg/d) alone (n=5310)
Number of subjects: 27347
Study 28898378 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=8102 for CEE+MPA, n=5429 for CEE alone)
Number of subjects: 27347
Study 28898378 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy (CEE+MPA or CEE)
Number of subjects: 27347
Study 25752195 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-hexyl-1,3-phenylenediol
Number of subjects: 59
Study 25752195 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 59
Study 24212847 — intervention group
Group type: EXPERIMENTAL
Intervention: Transconjunctival needling revision with 5-fluorouracil
Number of subjects: 40
Study 24212847 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (hypotensive eyedrops)
Number of subjects: 40
Study 22013796 — intervention group
Group type: EXPERIMENTAL
Intervention: Wangbi Tablet (WT)
Number of subjects: 160
Study 22013796 — intervention group
Group type: EXPERIMENTAL
Intervention: WT + Votalin Tablet
Number of subjects: 160
Study 22013796 — intervention group
Group type: COMPARATOR
Intervention: Votalin Tablet
Number of subjects: 160
Study 20001655 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan-based therapy
Number of subjects: 9193
Study 20001655 — intervention group
Group type: COMPARATOR
Intervention: Atenolol-based therapy
Number of subjects: 9193
Study 17284923 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 90
Study 17284923 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 90
Study 16230756 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct care providers with 1 to 2 years of experience
Number of subjects: 154
Study 16230756 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centered attitude
Number of subjects: 154
Study 16230756 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived competence in providing dementia care
Number of subjects: 154
Study 11900820 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of nicotine polacrilex
Number of subjects: 13
Study 11900820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 9873242 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive intervention program (lessons and group discussions on adolescent problems and eating disorders)
Number of subjects: 254
Study 9873242 — intervention group
Group type: COMPARATOR
Intervention: Control group (154 subjects)
Number of subjects: 254
Study 7669459 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral naproxen 1 g
Number of subjects: 80
Study 7669459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 2040354 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine surfactant (Curosurf, 200 mg/kg body weight)
Number of subjects: 164
Study 7044788 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg orgotein (intra-articular injections, 4 weekly)
Number of subjects: 40
Study 7044788 — intervention group
Group type: COMPARATOR
Intervention: Saline (intra-articular injections, 4 weekly)
Number of subjects: 40
Study 7044788 — intervention group
Group type: EXPERIMENTAL
Intervention: Orgotein
Number of subjects: 40
Study 7044788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31559433 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (3000 IU daily for 26 weeks)
Number of subjects: 66
Study 31559433 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 31559433 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 66
Study 28052977 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 4128
Study 28052977 — intervention group
Group type: COMPARATOR
Intervention: No diabetes mellitus
Number of subjects: 4128
Study 25037460 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion Dysregulation (ED)
Number of subjects: 171
Study 25037460 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-clinical and subclinical levels of depression
Number of subjects: 171
Study 25037460 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical levels of depression
Number of subjects: 171
Study 25607562 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-pulsed Nd:YAG 1064 nm laser intervention for fingernails (Group 1)
Number of subjects: 37
Study 25607562 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-pulsed Nd:YAG 1064 nm laser intervention for toenails (Group 2)
Number of subjects: 37
Study 21546102 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg clopidogrel
Number of subjects: 46
Study 21546102 — intervention group
Group type: COMPARATOR
Intervention: 75 mg clopidogrel
Number of subjects: 46
Study 19443430 — intervention group
Group type: EXPERIMENTAL
Intervention: CFAE ablation
Number of subjects: 41
Study 19443430 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation, roof line, and mitral isthmus ablation
Number of subjects: 41
Study 17360152 — intervention group
Group type: EXPERIMENTAL
Intervention: Ekman 60 Faces Test
Number of subjects: 25
Study 17360152 — intervention group
Group type: COMPARATOR
Intervention: Cognitively healthy subjects (HC)
Number of subjects: 25
Study 15498633 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue dye alone (Group A)
Number of subjects: 150
Study 15498633 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined blue dye and radioactive tracer (Group B)
Number of subjects: 150
Study 15498633 — intervention group
Group type: COMPARATOR
Intervention: Comparison of techniques
Number of subjects: 150
Study 11270920 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 17
Study 11270920 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 17
Study 9874861 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clonidine 150 micrograms
Number of subjects: 100
Study 9874861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 7979499 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin
Number of subjects: 24
Study 7979499 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (enteral nutrition or corticosteroids)
Number of subjects: 24
Study 7979499 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 24
Study 2692580 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin/clavulanate
Number of subjects: 185
Study 2692580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 29869405 — intervention group
Group type: EXPERIMENTAL
Intervention: L-T4
Number of subjects: 32
Study 29869405 — intervention group
Group type: EXPERIMENTAL
Intervention: T3
Number of subjects: 32
Study 29869405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 26565690 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Hatha Yoga (HIY) for 6 weeks (60 minutes once a week)
Number of subjects: 44
Study 23817506 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg
Number of subjects: 39
Study 23817506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 23166292 — intervention group
Group type: EXPERIMENTAL
Intervention: Study trials associated with accurate location memory
Number of subjects: 0
Study 23166292 — intervention group
Group type: COMPARATOR
Intervention: Study trials associated with inaccurate location memory
Number of subjects: 0
Study 23166292 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful encoding of voice information
Number of subjects: 0
Study 23166292 — intervention group
Group type: EXPERIMENTAL
Intervention: Trials for which both contextual features were later retrieved
Number of subjects: 0
Study 20460239 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified soymilk (20 mL with 185 kBq of 45Ca in 44 mg of calcium carrier)
Number of subjects: 12
Study 20460239 — intervention group
Group type: COMPARATOR
Intervention: Cow's milk
Number of subjects: 12
Study 17570262 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-chain triglyceride (MCT), 18 g/d for 90 days
Number of subjects: 40
Study 17570262 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (long-chain triglycerides, LCT)
Number of subjects: 40
Study 16034259 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 ml syringe training aid
Number of subjects: 64
Study 16034259 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 64
Study 12439536 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening primrose oil
Number of subjects: 120
Study 12439536 — intervention group
Group type: COMPARATOR
Intervention: Control oil for evening primrose oil
Number of subjects: 120
Study 12439536 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 120
Study 12439536 — intervention group
Group type: COMPARATOR
Intervention: Control oil for fish oil
Number of subjects: 120
Study 10406151 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-year-olds with uncorrected visual acuity below 0.5
Number of subjects: 6292
Study 10406151 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-year-olds with uncorrected visual acuity below 0.5
Number of subjects: 6292
Study 10406151 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-year-old girls in Nizwa, Dakhlia
Number of subjects: 6292
Study 10406151 — intervention group
Group type: COMPARATOR
Intervention: 12-year-olds in rural, remote areas
Number of subjects: 6292
Study 8665540 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (100 micrograms s.c.)
Number of subjects: 9
Study 8665540 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 9
Study 2209029 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibustrin
Number of subjects: 49
Study 2209029 — intervention group
Group type: COMPARATOR
Intervention: ASA and dipyridamole
Number of subjects: 49
Study 6996107 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg)
Number of subjects: 55
Study 6996107 — intervention group
Group type: EXPERIMENTAL
Intervention: Propoxyphene hydrochloride (64 mg)
Number of subjects: 55
Study 6996107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 30106311 — intervention group
Group type: EXPERIMENTAL
Intervention: Emulsified cod liver oil formulation
Number of subjects: 47
Study 29609568 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-session MAISHA curriculum delivered over 20 weeks
Number of subjects: 66
Study 29609568 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 66
Study 29609568 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-session MAISHA curriculum
Number of subjects: 66
Study 27236884 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with medicine (ACM) - electro-acupuncture combined with injection of dexmedetomidine
Number of subjects: 50
Study 27236884 — intervention group
Group type: COMPARATOR
Intervention: Conventional analgesia - injection of dexmedetomidine
Number of subjects: 50
Study 24872682 — intervention group
Group type: EXPERIMENTAL
Intervention: SDX (600 lipoprotein lipase‐releasing units/day intramuscularly for 15 days followed by 250 lipase‐releasing units every 12 hours orally for 6 months)
Number of subjects: 53
Study 24872682 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (compression therapy and surgery)
Number of subjects: 53
Study 22772512 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol-propofol infusion
Number of subjects: 60
Study 22772512 — intervention group
Group type: COMPARATOR
Intervention: Midazolam-propofol infusion
Number of subjects: 60
Study 20186889 — intervention group
Group type: EXPERIMENTAL
Intervention: TEP (totally extraperitoneal patch)
Number of subjects: 1512
Study 20186889 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein
Number of subjects: 1512
Study 20186889 — intervention group
Group type: EXPERIMENTAL
Intervention: TEP
Number of subjects: 1512
Study 17913000 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocaril Sensia (FSTB)
Number of subjects: 12
Study 17913000 — intervention group
Group type: EXPERIMENTAL
Intervention: Elgydium Interactive (ELTB)
Number of subjects: 12
Study 17913000 — intervention group
Group type: EXPERIMENTAL
Intervention: Elmex InterX (ETB)
Number of subjects: 12
Study 17913000 — intervention group
Group type: EXPERIMENTAL
Intervention: Butler 211 (BTB)
Number of subjects: 12
Study 17913000 — intervention group
Group type: COMPARATOR
Intervention: All toothbrushes
Number of subjects: 12
Study 16052120 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 U BoNT‐A
Number of subjects: 132
Study 16052120 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 U BoNT‐A
Number of subjects: 132
Study 16052120 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 U BoNT‐A
Number of subjects: 132
Study 16052120 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 132
Study 11978287 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin at 0.5 mg/kg per day for 6 months
Number of subjects: 117